Retnoningsih, Dewi
Unknown Affiliation

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Level of SARS-CoV-2 exposure post the CoronaVac vaccination in health workers at Dr. Saiful Anwar General Hospital, Malang Bormasa, Pelpina; Santoso, Sanarto; Diyah, Nurima; Wahono, Cesarius Singgih; Retnoningsih, Dewi
Journal of Clinical Microbiology and Infectious Diseases Vol. 4 No. 1 (2024): Available online: June 2024
Publisher : Indonesian Society for Clinical Microbiology (Perhimpunan Dokter Spesialis Mikrobiologi Klinik Indonesia)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.51559/jcmid.v4i1.46

Abstract

Introduction. COVID-19 is considered a new emerging infection due to SARS-CoV-2. CoronaVac refers to an inactivated SARS-CoV-2 vaccine obtaining EUL (Emergency use listing) from BPOM RI and WHO. This vaccine was previously reported to exhibit good efficacy in generating protective antibodies against SARS-CoV-2. Nevertheless, health workers in Indonesia might pose a high risk of COVID-19 exposure, leading to mortality. This study aims to identify the level of SARS-CoV-2 exposure to the CoronaVac vaccination in health workers at Dr. Saiful Anwar General Hospital, Malang. Methods. This study implemented analytical observational research with a prospective cohort approach on health workers at Dr. Saiful Anwar General Hospital, Malang, who received the 2nd dose of vaccination dose with a 14-day interval. All study subjects were observed for 6 months by examining the level of exposure to SARS-CoV-2 obtained from the results of nasopharyngeal and oropharyngeal swab examinations of SARS-CoV-2 RT PCR examination. Categorical data were tested by using Chi-square or Fisher exact. Results. From 184 samples, the SARS-CoV-2 exposure indicated several outcomes: positive 57 (31 %) and negative 127 (69%). Severity degrees of COVID-19 disease were asymptomatic 17 (29.8%), mild 37 (64.9), moderate 3 (5.3%), severe 0 (0%), and there were no mortality cases. The time (duration) of exposure to SARS-CoV-2 post-CoronaVac vaccination indicated that the highest number of participants with positive RT-PCR swab results post-vaccination was in the fifth month of the CoronaVac vaccination with 41 people. Clinical symptoms of SARS-CoV-2 exposure experienced by participants post the CoronaVac vaccination included pneumonia (3 people), cough and cold (27 people), fever (22 people), myalgia (17 people), and sore throat (11 people). There was no significant relationship p value > 0.05 between gender, age, comorbidities, and Ct value on SARS-CoV-2 exposure post CoronaVac vaccination in health workers at Dr. Saiful Anwar General Hospital, Malang. Conclusion. There was SARS-CoV-2 exposure of 31% post the CoronaVac vaccination in health workers at Dr. Saiful Anwar General Hospital, Malang.
Comparison of synergistic effects of multiple combinations of anti-pseudomonas antibiotics against Pseudomonas aeruginosa pan drug resistance in in vitro test with AZDAST Method Putri, Citra Destya Rahma; Etty Fitria Ruliatna; Retnoningsih, Dewi; Rahayu, Siwipeni Irmawanti; Noorhamdani
Journal of Clinical Microbiology and Infectious Diseases Vol. 4 No. 1 (2024): Available online: June 2024
Publisher : Indonesian Society for Clinical Microbiology (Perhimpunan Dokter Spesialis Mikrobiologi Klinik Indonesia)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.51559/jcmid.v4i1.48

Abstract

Background: Antimicrobial resistance is a global threat to public health. Pseudomonas aeruginosa Pan Drug-Resistant requires the latest antimicrobials. This limitation of therapy requires a breakthrough in the treatment of this infection. Combining antimicrobials with a synergistic effect is thought to increase the cure rate in clinical use. This study aimed to determine the synergistic effect of several combinations of anti-pseudomonas antibiotics against Pan Drug-Resistant Pseudomonas aeruginosa in an in vitro test using the AZDAST method. Method: An Antibiotic combination test was carried out using the AZDAST method to assess in vitro synergistic activity. The antibiotic single disk used was Amikacin 30 µg, Ceftazidime 30 µg, Meropenem 10 µg, Ciprofloxacin 5 µg; double disk antibiotic is Amikacin 30 µg, Ceftazidime 30 µg, Meropenem 10 µg, Ciprofloxacin 5 µg and combination antibiotic disks Amikacin 30 µg-Ceftazidime 30 µg, Amikacin 30 µg-Meropenem 10 µg, Amikacin 30 µg-Ciprofloxacin 5 µg in which two antibiotic paper disks are combined stacked together, with a 24 mm gap between the other antibiotic combinations. Result: The results showed that combining the four antibiotics had a synergistic effect. The zone of inhibition resulting from testing the combination of several antibiotics against Pan Drug Resistant Pseudomonas aeruginosa showed no statistical significance (p > 0.05) compared to all antibiotics and comparisons in the combination group of antibiotics only. Conclusion: The combination of anti-pseudomonas antibiotics synergizes with Pan Drug-Resistant Pseudomonas aeruginosa in the AZDAST method in vitro test.